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Abstract: Cytochrome P450 17A1 (CYP17A1) is an important drug target for
castration resistant prostate cancer. It is a bi-functional enzyme, catalyzing
production of glucocorticoid precursors by hydroxylation of pregnene-nucleus,
and androgen biosynthesis by a second C C lyase step, at the expense of
glucocorticoid production. Cytochrome b5 (cyt b5) is known to be a key
regulator of the androgen synthesis reaction in vivo, by a mechanism that is
not well understood. Two hypotheses have been proposed for the mechanism
by which cyt b5 increases androgen biosynthesis. Cyt b5 could act as an
allosteric effector, binding to CYP17A1 and either changing its selective
substrate affinity or altering the conformation of the P450 to increase the
catalytic rate or decrease unproductive uncoupling channels. Alternatively, cyt
b5 could act as a redox donor for supply of the second electron in the P450
cycle, reducing the oxyferrous complex to form the reactive peroxointermediate. To understand the mechanism of lyase enhancement by cyt b5,
we generated a redox-inactive form of cyt b5, in which the heme is replaced
with a Manganese-protoporphyrin IX (Mn-b5), and investigated enhancement
of androgen producing lyase reaction by CYP17A1. Given the critical
significance of a stable membrane anchor for all of the proteins involved and
the need for controlled stoichiometric ratios, we employed the Nanodisc
system for this study. The redox inactive form was observed to have no effect
on the lyase reaction, while reactions with the normal heme-iron containing
cyt b5 were enhanced ∼5 fold as compared to reactions in the absence of cyt
b5. We also performed resonance Raman measurements on ferric CYP17A1
bound to Mn-b5. Upon addition of Mn-b5 to Nanodisc reconstituted CYP17A1,
we observed clear evidence for the formation of a b5-CYP17A1 complex, as
noted by changes in the porphyrin modes and alteration in the proximal Fe
S vibrational frequency. Thus, although Mn-b5 binds to CYP17A1, it is unable
to enhance the lyase reaction, strongly suggesting that cyt b5 has a redox
effector role in enhancement of the CYP17A1 mediated lyase reaction
necessary for androgen synthesis.
Keywords: CYP17A1, Cytochrome b5, Redox donor, Androgen synthesis,
Nanodiscs
Abbreviations
 Cyt b5, cytochrome b5;
 Mn-b5, manganese protoporphyrin IX substituted cyt b5;
 DHEA, dehydroepiandrosterone;
 PREG, pregnenolone;
 OH-PREG, 17α-hydroxypregenolone
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1. Introduction
The role of cytochrome b5 in P450 mediated metabolism has
been the subject of intense debate for decades. Although its essential
role in the fatty acid biosynthetic pathways is well appreciated,1 early
work with hepatic drug metabolizing enzymes often yielded conflicting
results. For instance, Sato and coworkers suggested that the binding
of cytochrome b5 (cyt b5) to cytochrome P450 elicited a structural
change in the enzyme which activated product turnover, either by
increasing the inherent catalytic rate or by inhibiting non-productive
auto-oxidative shunt processes (Fig. 1).2 Alternatively, as cyt b5
contains a bis-imidazole coordinated heme, direct transfer of electrons
from cyt b5 to P450 has been proposed.2,3 In this latter role, the
relatively high redox potential of cyt b5 (∼0 mV versus Normal
Hydrogen Electrode Ref.4) suggests that electron transfer to ferric
P450 (redox potential ∼ −300 mV vs. NHE) is unfavorable. Hence it
was suggested that the redox function of cyt b5 involved electron
transfer to the ferrous dioxygen intermediate which has a redox
potential near 0 mV5 thus providing the “second electron” in the
normal monooxygenase stoichiometry. In an attempt to differentiate
between these two roles, Coon and co-workers reconstituted apo-cyt
b5 with manganese protoporphyrin IX.6 They observed no reduced Mnb5 in the presence of cytochrome P450 reductase (CPR) and NADPH,
whereas iron cyt b5 was rapidly reduced. Hence Mn-b5 is incapable of
any electron transfer to the P450. From their experiments on various
P450 reactions they concluded that cyt b5 effects depend on the
specific P450 in question, the substrate being examined, and molar
ratio of CPR to P450. This suggested that their observations could not
be explained solely by a simple electron transfer role and some effects
may also be caused by possible conformational changes caused by cyt
b5 binding. While the role of cyt b5 in drug metabolism continues to be
explored, a more interesting and potentially critical function of cyt b5,
is in human steroid biosynthesis.
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Fig. 1. Cytochrome P450 reaction cycle. Black arrows represent the path followed for
CYP17A1 mediated hydroxylation chemistry, while red arrows represent the CYP17A1
mediated carbon-carbon scission reaction, the lyase chemistry. The first reduction is
indicated as being carried out by CPR, while the second electron can be donated by
either CPR or cytochrome b5. (For interpretation of the references to colour in this
figure legend, the reader is referred to the web version of this article.)

The synthesis of androgens, estrogens and corticosteroids
involves multiple P450 catalyzed reactions. Cytochrome P450 17A1
(CYP17A1) is a key player in these reactions, being responsible for
catalyzing 17α-hydroxylation of pregnenolone and progesterone
Biochemical and Biophysical Research Communications, Vol 477, No. 2 (August 19, 2016): pg. 202-208. DOI. This article is
© Elsevier and permission has been granted for this version to appear in e-Publications@Marquette. Elsevier does not
grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission
from Elsevier.

4

NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be
accessed by following the link in the citation at the bottom of the page.

followed by C17C20 bond scission in a separate lyase reaction to form
dehydroepiandrosterone (DHEA) and androstenedione (AD)
respectively (Fig. 2). The hydroxylation reactions occur throughout a
person’s lifetime, and when a person approaches adrenarche, the
hydroxylated products can be shunted towards the subsequent step of
formation of androgenic precursors by CYP17A1 in addition to the
production of glucocorticoids.7 The presence of membrane bound form
of cyt b5 has been known to selectively and significantly enhance the
rate of the lyase reaction.8 Mutations of CYP17A1 surface residues:
R347, R358 and K89 which are known to interact with cyt b5, have
been shown to cause impairment of lyase activity.9 In a recent report,
significant lyase impairment was shown in mice testicular Leydig cells
lacking cyt b5.10 Additionally, male patients with mutations causing a
lack of cyt b5 present with pseudo hermaphroditism, while high cyt b5
expression in adrenocortical adenomas in Cushing’s syndrome patients
has been associated with increased androgen synthesis.11 Clearly, cyt
b5 has a physiological significance in maintaining normal levels of
androgen synthesis. The nature of this role has been long
debated,8,12,13,14 with Auchus and coworkers studying lyase activity in
recombinant yeast using apo b5 which stimulated the lyase reaction,
leading these workers to conclude that there is no redox role.15 A
similar report from Akhtar and coworkers mentions unpublished results
demonstrating lyase enhancement in a reconstituted system utilizing
Mn-b5.9 On the contrary, Estabrook and others demonstrated in an
in vitro reconstituted system in the presence of lipids that a zinc
substituted derivative of b5 did not stimulate the lyase activity of
CYP17A1, and that the previous reports of rate enhancement by apo b5
are the result of transfer of the heme group from the P450 to apo b5
forming the holoenzyme.16 Another property of cyt b5 that complicates
all previous reports is the need for an intact membrane to influence
the P450 activity.17 Given the key importance of cyt b5 in the
regulation of androgen synthesis, it is imperative that this disparity
about the role of cyt b5 be solved in a reproducible system
representative of the membrane environment of these proteins. To this
end, we employ the Nanodisc system to reconstitute CYP17A1, CPR
and cyt b5 in controlled stoichiometric ratios. We reconstituted cyt b5
with manganese protoporphyrin IX and investigated the rate of lyase
reaction by CYP17A1 in Nanodiscs, with iron containing cyt b5, or with
Mn-protoporphyrin IX substituted form of cyt b5 (Mn-b5) and compared
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each case versus the rate in the absence of cyt b5. In humans,
androgens are primarily derived from the 17α-hydroxypregnenolone
substrate, therefore we decided to investigate this reaction to
determine whether cyt b5 is a redox donor in CYP17A1 mediated lyase
reaction for androgen synthesis. Additionally, we probed the ferric
resting state of CYP17A1 in the presence of native substrates to
indicate formation of the b5-CYP17A1 complex.

Fig. 2. CYP17A1 catalyzed reactions in steroidogenesis.
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2. Materials and methods
2.1. Expression and purification of recombinant
proteins, Nanodisc assembly
The expression and purification of CYP17A1 was performed as
described.18 The expression and purification of membrane scaffold
protein and cyt b5 were performed as described.19,20 Nanodiscs with
CYP17A1 were assembled as documented.21 Incorporation of CPR and
cyt b5 into purified CYP17A1 Nanodiscs was performed by direct
addition of CPR and/or cyt b5 in 2–4-fold molar excess, as
documented.22,23,24

2.2. Reconstitution of cyt b5 with manganese
protoporphyrin IX
Cyt b5 was reconstituted with Mn-protoporphyrin IX according
to,6 with the following changes: After performing buffer exchange with
G-25 column to separate unbound Mn-protoporphyrin IX, the eluate
was run through a DEAE-cellulose column, equilibrated with 25 mM
Tris acetate (pH 8.0), 1 mM EDTA and 10 mM sodium cholate. A linear
salt gradient was formed using the equilibration buffer supplemented
with 1 M NaCl. Mn-b5 fractions which were characterized on the basis
of their observed Rz ratios, were pooled and rigorously dialyzed
against 100 mM potassium phosphate buffer (pH 7.4) and flash frozen
in liquid nitrogen before being stored at −80 °C until use.

2.3. Spectroscopic characterizations of Nanodisc
incorporated CYP17A1 and of Mn-b5
Nanodisc incorporated CYP17A1 was characterized by UV–visible
spectroscopy in a Cary 300 UV–visible spectrophotometer. The amount
of P450 was determined by change in spin shift upon pregnenolone
binding using ε390−ε417 = 100 mM−1 cm−1.25 Mn-b5 was quantified using
UV–visible spectroscopy using ε368 = 50 ± 2 mM−1 cm−1 and
ε468 = 38 ± 1.5 mM−1 cm−1.6 Purity and identity of all proteins was
confirmed by denaturing electrophoresis and MALDI-mass
spectrometry.
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2.4. Determination of NADPH oxidation rates
NADPH oxidation rates and product formation rates were
determined with 365 pmoles of CYP17A1 in Nanodiscs reconstituted
with 4-fold CPR, with/without the addition of 4-fold cyt b5. The solution
was brought to 1 mL by the addition of 100 mM potassium phosphate
buffer (pH 7.4) containing 50 mM NaCl and 50 μM 17αhydroxypregnenolone (Sigma) in a stirred quartz cuvette. The solution
was equilibrated at 37 °C by incubation for 5 min and reaction was
initiated by addition of NADPH solution. The NADPH consumption was
monitored by change in absorbance at 340 nm for 15 min and the
linearity was verified. At 15 min the reaction was quenched by adding
50 μL 8.9 N sulfuric acid. Each sample was flash frozen in liquid
nitrogen and stored at −80 °C until product analysis. These reactions
were performed in a Cary 300 UV–visible spectrophotometer fitted
with magnetic stirrer and Peltier temperature controller.

2.5. Determination of product formation rates
Frozen samples were thawed and extraction of analytes was
performed as previously documented.23 The product analysis was
performed by gas chromatography with a DB-17 phenol substituted
siloxane column and a flame ionization detector on a Hewlett-Packard
6890 gas chromatograph, and the chromatograms were processed
with Grams/32 AI software.

2.6. Preparation of Raman samples
CYP17A1 incorporated in Nanodiscs in 100 mM potassium
phosphate buffer (pH 7.4) was concentrated to 200 μM and 2-fold
excess of Mn-b5 was added from a 400 μM solution in the same buffer.
The resultant solution incubated at 37 °C for 15 min. Substrate was
added to each sample from methanolic stocks such that the final
concentration was 420 μM.24 Finally, ultrapure glycerol was added to a
concentration of 15% (v/v); i.e., the final concentration of CYP17A1
was calculated to be 85 μM. The samples were flash frozen in liquid
nitrogen and stored at −80 °C until analyzed.
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2.7. Resonance Raman spectroscopy
To determine the effect of cyt b5 on the heme stretching modes
in ferric CYP17A1, we employed the Mn reconstituted form of cyt b5.
This was done to prevent interference from the heme of cyt b5 as was
done previously by Mak et al. in rR studies on CYP2B4.26,27 We
acquired resonance Raman spectra after adding 2-fold and 4-fold
excess of Mn-b5. The high frequency spectra were acquired using the
406.7 nm excitation line from a Krypton ion laser (Coherent Innova
Sabre Ion Laser) and changes in the ν(FeS) stretching mode were
investigated using the 356.4 nm excitation line from the same laser, a
wavelength known to selectively enhance this mode.28 The RR spectra
of all samples were measured using a Spex 1269 spectrometer
equipped with a Spec-10 LN liquid nitrogen-cooled detector (Princeton
Instruments, NJ). The laser power was adjusted to ∼10 mW at the
sample. All samples were measured in a spinning NMR tube to avoid
local heating and protein degradation. The spectra were collected
using a 180° backscattering geometry, with the laser beam being
focused as a line image on the sample tube using a cylindrical lens.
Spectra were calibrated with data acquired for fenchone and processed
with Grams/32 AI software (Galactic Industries, Salem, NH).

3. Results
3.1. Reconstitution and characterization of Mn-b5
Mn-b5 was successfully reconstituted from a purified preparation
of apo-cyt b5. The complete reconstitution was confirmed by UV–
visible spectroscopy. SDS-PAGE analysis and MALDI-MS using a
sinapinic acid matrix confirmed the presence of highly purified and full
length protein construct of Mn-b5 as well as cyt b5 (data not shown).

3.2. NADPH oxidation and catalytic turnover of 17αhydroxypregnenolone in the presence of cyt b5 or Mn-b5
The rates of NADPH oxidation and product formation in the
presence of cyt b5 and Mn-b5 were compared to the rates in the
absence of any added cyt b5. The presence of cyt b5 increases the
product formation rate ∼5 fold, while the addition of Mn-b5 does not
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cause any change (Fig. 3A). The rates of NADPH oxidation were close
in value in all three cases, 54 ± 1.3 min−1 for cyt b5, 51 ± 1.0 min−1
for Mn-b5 and 46 ± 1.9 min−1 for reactions in the absence of any b5.
The efficiency of coupling was calculated as the ratio of product
formation rate to the rate of NADPH consumption. This was seen to be
maximal in the reactions with cyt b5, while reactions with no b5 and
with Mn-b5 had similar coupling efficiency (Fig. 3B).

Fig. 3. Comparison of CYP17A1 catalyzed lyase reactions with 17α-hydroxypregnenolone as substrate, with no cytochrome b5 present, or with Mn-b5, or native
cytochrome b5. (A) DHEA product formation rates (B) Coupling efficiencies (calculated
as the percent ratio of amount of product formed to the amount of NADPH consumed).
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3.3. Resonance Raman spectroscopy on Mn-b5 binding
to ferric CYP17A1
As was reported in an earlier work,29 binding of pregnenolone to
substrate-free CYP17A1 causes a spin state conversion from almost
pure low spin (LS) to largely high spin (HS) form, while binding of
17α-hydroxypregnenolone generates a lower HS fraction. The
persistence of more LS component being attributed to the tendency of
the 17α-hydroxy fragment of the substrate to directly interact with the
heme iron or promote retention of distal pocket water molecules. In
the present work, additions of Mn-b5 to substrate-bound forms of
CYP17A1, creating 2-fold excesses relative to the enzyme, cause
relatively small increases of the LS component in these samples. This
is reflected in the resonance Raman (rR) spectra illustrated in Fig. 4
for the samples bearing a 2-fold excess of Mn-b5. As can be seen in
trace B, pregnenolone bound CYP17A1 interacting with Mn-b5 shows a
spectrum similar to that for the sample without Mn-b5 (trace A); they
both exhibit a strong isolated ν3 mode at 1488 cm−1 and a small signal
for LS population near 1500 cm−1. Employing a procedure developed in
our laboratory by Mak et al.,30 it is possible to estimate the spin state
population using the intensity ratio of IHS/ILS equal to 1.24. Using this
value, the HS population of pregnenolone bound CYP17A1 in the
presence of a 2-fold excess of Mn-b5 is calculated to be 80%, close to
the value observed in the absence of Mn-b5. Similarly, it is noted that
the HS component changes from ∼57% to ∼50% when a 2-fold excess
of Mn-b5 was added into 17α-hydroxypregnenolone bound CYP17A1
(Fig. 4 right panel, trace D). These remained nearly the same even in
the presence of 4-fold Mn-b5, indicating that all of CYP17A1 binding
sites for cyt b5 have been occupied (data not shown). In addition to
the relatively minor effects on spin state populations, as can be seen
in Fig. 4, it is important to emphasize that the frequencies observed
for both the low energy and high energy internal modes of the heme
prosthetic group do not shift relative to those observed for the
corresponding samples without Mn-b5, implying that the interaction
with Mn-b5 does not induce significant structural changes of the heme
macrocycle or its peripheral substituents in the substrate-bound ferric
enzyme. Though minimal effects were observed for spin state
populations and heme structure, it is noted that association of
CYP17A1 with Mn-b5 increases the strength of Fe S linkage,
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demonstrating the formation of a CYP17A1:Mn-b5 complex. This is
evident from viewing the inserts for the low-frequency spectra in
Fig. 4, where the ν(Fe S) stretching modes occurring in samples with
the excess Mn-b5 appear at 350 cm−1, while those previously reported
for the same samples of CYP17A1 in Nanodiscs without Mn-b5 appear
at 347 cm−1.29

Fig. 4. Resonance Raman Spectra of CYP17A1 ± Mn-b5. The right panel shows the
high-frequency region of the acquired spectra, while the left panel shows the low
frequency region; the spectra were acquired using the 406.7 nm excitation line from a
Krypton ion laser, noting that the inset bands in the low frequency region were
acquired with the 356.4 nm excitation line from the same laser, a wavelength that
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selectively enhances the ν(Fe
S) stretching mode.28 Spectra traces in B and D are
the resulting traces after subtraction of spectra obtained for samples containing the
equivalent concentration of Mn-b5.

4. Discussion
CYP17A1 is a critical enzyme in steroidogenesis, lying at the
branch point of glucocorticoids synthesis and androgen synthesis. It
performs hydroxylation on the pregnene-nucleus to form hydroxylated
products which can either be diverted to glucocorticoid synthesis, or
undergo a C C bond lyase reaction by CYP17A1 to produce
androgens. Cytochrome b5 is known to be the chief regulator of
CYP17A1 reactivities in vivo, yet the nature of interactions of CYP17A1
with cyt b5 is not clearly understood. Cyt b5 is known to enhance the
lyase reactions from 5 to 10 fold. Whether cyt b5 acts as an allosteric
modulator or if it functions as a second electron donor has long been
debated,15,16 and conflicting reports from various groups are
complicated by the fact that these studies were carried out in
uncontrolled conditions where aggregation states and stoichiometries
of interactions were not known.15,31,32 Scott and coworkers have used
solution NMR with soluble forms of the proteins to study the
conformational changes occurring in CYP17A1 bound to lyase
substrates upon cyt b5 binding and associated them with an allosteric
role for cyt b5,12,33 although not directly addressing a possible redox
role. The application of Nanodisc technology to this system is therefore
an effective solution, enabling us to study reactions in controlled
stoichiometries in a native-like membrane environment.
We reconstituted cyt b5 with Mn-protoporphyrin IX, which is
known to be redox inactive under these conditions,6 and tested the
rate of lyase reaction in 17α-hydroxypregnenolone in the presence and
absence of cyt b5, and also in the presence of Mn-b5. Reactions with
Mn-b5 showed no enhancement of the rate of DHEA formation, which
suggests very strongly that cyt b5 has a definite redox donor role in
the CYP17A1 lyase chemistry. Importantly, presence of cyt b5
increases the coupling efficiency about 5-fold. Given the relatively high
redox potential of cyt b5 (∼0 mV NHE),4 its redox role is limited to
reduction of the oxy-complex,5 giving rise to the nucleophilic peroxospecies, the reactive intermediate responsible for carbon-carbon bond
scission.23,34 An enhanced reduction rate of the oxy-complex is
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expected to increase the steady-state concentration of the
peroxoanion, which in the absence of cyt b5 is depleted through nonproductive release of hydrogen peroxide. Our resonance Raman data
with Mn-b5 binding to ferric CYP17A1 indicate no major structural
changes of the heme planar modes, whereas on the proximal side, Fe
S bond was observed to get strengthened when Mn-b5 was bound.
Clearly, Mn-b5 binds to CYP17A1, but is incapable of enhancing the
lyase activity, the latter being enhanced if the native iron containing
cyt b5 is bound. Taken together, these experiments provide strong
evidence that cyt b5 is serving as a redox partner in CYP17A1 catalytic
cycle, most likely delivering a second electron to the oxy-complex and
facilitating formation of the peroxo-ferric complex, which recent
evidence shows to be the catalytically active intermediate in the lyase
reaction.34 This result is in agreement with conclusions on the role of
cyt b5 in CYP2B4 catalysis.14,35 Although our results cannot disprove
the presence of functionally important allosteric interactions between
cyt b5 and CYP17A1, the lack of any effect of Mn-b5 on the rate of
turnover of 17α-hydroxypregnenolone, as compared with 5-fold
acceleration of this reaction in the presence of cyt b5, suggests that
these allosteric interactions do not play significant role in the human
CYP17A1 mediated catalysis of lyase reaction.
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